Singapore has a strong reputation for health services and healthcare systems; in 2000, the country was ranked sixth in the world by the World Health Organization. Public hospitals have autonomy over management decisions, and compete with one another for patients. General hospitals have a variety of functions and services; they mainly represent multi-disciplinary acute inpatient and specialist outpatient services, have 24-hour emergency centers, and often specialize in a specific field of medicine (cancer research, neuroscience, dental care, cardiac care, etc.). Singapore has an array of hospitals and health services available, as well as community hospitals that exist as an intermediate form of healthcare for people who do not require the services of a general hospital but cannot cope at home.
The funding behind Singapore’s public health sector can be broken down into the Ministry of Health of Singapore, Medisave, MediShield Life, and MediFund. Singapore’s healthcare system uses a mixed financing system that includes nationalised life insurance schemes and deductions from the compulsory savings plan, or Central Provident Fund (CPF), for working Singaporeans and permanent residents.
Top 20 HealthCare Startups in Singapore:
EndoMaster is a medical device company that is developing a novel robotic-assisted surgical system that will significantly advance current endoscopic surgeries. This will enable surgeons to perform incision-less surgery that could only be performed by open and laparoscopic surgery before. EndoMaster has developed a novel robotic-assisted surgical system for endoscopy that will significantly advance current endoscopic surgeries and enable surgeons to perform incision-less surgeries that could only be performed by open and laparoscopic surgery before. EndoMaster’s robotic system will enable minimally invasive surgery in the body with increased precision and intuitiveness and reduced surgery time. This will reduce patient discomfort as well as the risk of procedural and post-operative complications.
2. Neuroglee Therapeutics
Neuroglee Therapeutics discovers, develops, and commercializes software as medical treatment for patients with neurodegenerative diseases. By combining best-in-class cognitive rehabilitation strategies and machine learning approaches, their digital therapeutic and monitoring tools empower patients, families and clinicians by helping to preserve cognition and independence. Their lead product, NG-001 is a prescription software intended for treatment of MCI and patients with early stage Alzheimer’s Disease.
3. Biolidics Limited
Biolidics Ltd, formerly known as Clearbridge BioMedics, is a medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. Biolidics has developed patented technology and solutions with the potential to serve as a platform technology for the diagnosis, prognosis, treatment selection and treatment monitoring of various types of cancers.
The ClearCell® FX1 System by Biolidics is a fully automated CE-IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patient’s body.
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company’s proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery programs ongoing and will be progressing towards IND-enabling studies and entry into the clinic.
Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDx™ system, the world’s first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate. Endofotonics is currently ran by a lean team of highly skilled and specialized engineers and PhD executives, with knowledge ranging from optics to biomedical, and skills from academic research to industrial product development. Overseeing Endofotonics as a business, the company is supported by board of directors and engineering scientific board that comprises of founders and thought leaders in their own field.
Started in 2012, MyDoc has become one of Asia’s top digital healthcare companies with the goal to create an efficient and effective healthcare ecosystem for patients and doctors. MyDoc offers simple, easy-to-use and time-saving services for convenient and easily accessible healthcare. MyDoc believes the key to digital health is to integrate healthcare into one, easy-to-use platform. Headquartered in Singapore, MyDoc has built a comprehensive healthcare services network across Asia that connects organisations, governments and patients to doctors, pharmacies, insurers and laboratories.
Working with their partners in Singapore, Malaysia, Sri Lanka, and other markets, MyDoc has developed a modular, easy-to-deploy solution that can be quickly tailored to solving your healthcare needs and engaging your customers in a meaningful and effective manner.
Founded in 2017, Speedoc is a virtual clinic and healthcare solutions platform that allows users to seek medical care and services from home. As a virtual clinic and hospital care provider combining physical-digital services to challenge the traditional centralized, facility-based model, Speedoc believes that this will be the solution for the aging population faced by many countries in the region as the demand for medical care increases.
Their services include house call doctors, nurses, medications delivery; and is complemented by telemedicine, remote diagnostics and health monitoring. With Speedoc, home medical services need not be limited to only certain groups of patients, but to everyday people who may require GP or A&E visits for themselves or their loved ones.
UCARE.AI aim to apply their AI’s power to accurately predict all aspects of the healthcare industry in helping patients, providers, caregivers and payers navigate each patient journey. They’re interested in your personal and professional experience. Applications from self-motivated talent with a diverse background and collaborative spirit are always welcome. You will be helping to lead healthcare to a more effective, personalised, and preventative care. Just as they value the health of the world’s people, they value that of our employees, too. They’ll support you in your individual growth and continuous learning.
Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Their goal is to extend healthy lifespan dramatically and delay age-related health issues. They identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.
Healint designs state-of-the-art solutions for chronic pain diseases to empower people by embedding AI in mobile phones and analysing in record time health data. With over 2 million registered users, Migraine Buddy is the #1 migraine app in the world. Track your migraine, understand your triggers, and share your migraine history with your doctor to get the best possible treatment. It is the most popular condition-specific app in the world. Using deep analytics and machine learning, Healint generates real-world evidence for patients, physicians, and researchers to improve treatment outcomes and expedite clinical trials.
11. Aslan Pharmaceuticals
ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore.
Their leading investors are Armentum Partners, Surveyor Capital and Vivo Capital.
12. Doctor Anywhere
At Doctor Anywhere, they are guided by the core belief that healthcare should be simple, accessible and efficient for everyone. Since their launch in 2017, they’ve been disrupting the healthcare industry by developing innovative solutions to bridge gaps in the healthcare ecosystem. Their services integrate both digital and offline platforms to empower users to take charge of their health. Headquartered in Singapore, we have regional offices in Malaysia, Thailand, Philippines, Vietnam, and India, serving more than 2.5 million (and growing) users across Asia.
Their leading investors are Square Peg Capital and Kamet Capital Partners.
13. CXA Group
CXA Group is Asia’s one-stop, predictive and data intelligence platform for better health, wealth and wellness choices. Through the CXA platform, employers can empower employees with access to personalised health and lifestyle offerings, with clear and quantifiable ROI for the business. They enable employers to leverage their existing healthcare and insurance spend to pay for flexible benefits, corporate wellness and disease management initiatives in order to improve health, combat chronic disease and reduce costs while allowing for employee personalization via an e-wallet and AI.
Their leading investors are MDI Ventures, B Capital Group, Singtel Innov8 and HSBC.
Zenyum is on a mission to help Asia smile more. They’re a consumer-focused healthcare brand that removes medical jargon, cancelled appointments, price variations and puts convenience at the centre of your smile journey. Affordable dental treatment that actually works. Founded in 2018 in Singapore, Zenyum provides Smile Cosmetics, produced under the highest quality standards. Led by a team of experienced tech entrepreneurs and doctors, they bring the highest level of care to our customers by partnering with experienced local dentists across Asia. Zenyum operates in Singapore, Malaysia, Hong Kong, Indonesia, Taiwan, Thailand, and Vietnam.
Their leading investors are L Catterton Asia, RTP Global, TNB Aura and Partech.
15. Engine Biosciences
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Their proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. They are actively applying the platform internally and with partners across a range of disease indications.
Their leading investors are Polaris Partners, Baidu Ventures and EDB.
Homage is a leading technology-driven care and health services platform that combines curated and trained care professionals with smart technology to manage and provide on-demand holistic non-medical and medical services to seniors and adults, allowing them to age and recover at home with grace, control and dignity. Homage’s core care services include Disability and Care Assessments, Activities of Daily Living (ADL) assistance, Nursing Procedures and Rehabilitation services, including Physiotherapy, Speech Therapy and Occupational Therapy. Additionally, Homage Health provides health screening, mobile medicine, telemedicine, ambulance and medication delivery services.
Their leading investors are Sheares Healthcare, SeedPlus and East Ventures.
Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Founded in 2015, Holmusk is headquartered in Singapore and New York City with offices in Basel, London, Malaysia, Shanghai, and Durham (North Carolina). Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort. Holmusk’s vision is to build the world’s largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools.
Their leading investors are Optum Ventures, Health Catalyst Capital and Heritas Capital.
18. AUM Biosciences
AUM is a clinical-stage biopharmaceutical company aiming to democratize R&D with a focus on discovering, acquiring, and developing novel therapeutics in oncology. The company holds exclusive worldwide rights in all disease indications for 2 first-in-class technologies with strong composition of matter patents in all major territories. MNK Inhibition and Multi-Kinase Inhibition (PIM/PI3K/mTOR). AUM utilizes a proprietary partnered AI-augmented platform to systematically discover and develop targeted cancer therapies focused on genetic targets. AUM’s most advanced program is Phase II ready in colorectal cancer, and 2 additional pre-clinical programs have clear pathways to orphan drug designation.
Their leading investors are Everlife and SPRIM.
DocDoc is the world’s first patient intelligence company. Their vision is to empower patients to make data-driven healthcare decisions which are safe, transparent, and fair. They use technology in conjunction with medically trained professionals to optimise healthcare outcomes and cost, and enhance the patient’s end-to-end healthcare journey. DocDoc combines AI-powered doctor discovery, telemedicine, and digital Third Party Administrator services onto a single platform. With this platform, DocDoc enables insurance companies to offer a differentiated product in a crowded market, employers to attract and retain world-class employees, and governments to improve accessibility and affordability of healthcare services for their citizens.
Their leading investors are Adamas Finance Asia, CyberPort Marco Fund and Yee How Choong.
20. Attune Technologies
Attune Technologies is a next-generation healthcare IT company that has pioneered Cloud based products designed to help the entire healthcare ecosystem. Attune’s solutions seamlessly integrate Labs, Hospitals, Pharmacies, Blood Banks, Radiology, Medical Devices (IoT), Insurance Companies, and Accounting resulting in increased revenues and operational efficiency. Attune’s solutions can be deployed across the spectrum of organizations – starting from single physician clinics to a network of healthcare providers making it the largest Cloud based healthcare IT service provider in the region. Funded by Norwest Venture Partners and Qualcomm Ventures, Attune is headquartered in Singapore and supports over 10 million patient health records serving 200+ clients spread across 15 countries in the Indian Subcontinent, South East Asia, Middle East and Africa.
Their leading investors are Norwest Venture Partners and Qualcomm Ventures.
For any corrections or nominations, Please mail email@example.com